Business
HCi Viocare Commences Trading on Berlin Stock Exchange
HCi Viocare Commences Trading on Berlin Stock Exchange.
About this update from Rafina Innovations Inc.
[{"type":"text","content":"\n \n \n HCi Viocare Commences Trading on Berlin Stock Exchange\n \n \nHCi Viocare Commences Trading on Berlin Stock Exchange\n \n GLASGOW, SCOTLAND--(Marketwired - Apr 27, 2016) - HCi Viocare (OTCQB: VICA), a Nevada corporation (the \"Company\"), today announced it has been approved for a joint listing on the Berlin Stock Exchange (the \"BSE\"). The Company is currently trading on the OTC Markets Group, Inc. QB Tier (OTCQB) in the United States and has decided, in the best interests of its shareholders, to list on a European platform to better accommodate its European shareholders and investors. The Company has received the trading symbol \"HCF\" on the BSE, Security WKN # A2AG73 and ISIN # US40416H2058.\n The Berlin Stock Exchange or Börse Berlin AG is one of the oldest stock exchanges in Germany. The BSE has pursued a successful niche strategy since the mid-nineties, with a particular focus on trading the widest possible range of foreign stocks.\n Sotiris Leontaritis, HCi Viocare's CEO, comments: \"This dual listing improves liquidity and opens up a much broader range of funders, investors, and potential shareholders to the Company. It will allow HCi Viocare to better serve its current and future European investors.\"\n The Company believes a dual listing on the Berlin Stock Exchange will:\n \n \n Improve the Company's image, reputation and prestige as a global participant;\n \nGreatly expand the ability of the Company to raise equity or debt financing in the future;\n \nIncrease the Company's trading volume and liquidity;\n \nImprove the Company's shareholder relations; and\n \nVastly enhance the visibility of the Company among overseas investors and consumers.\n \n \n About HCi Viocare \n HCi Viocare has a dual, complementary business model of 1) creating the first cross-border independent chain of Prosthetics & Orthotics (P&O) and Diabetic Foot clinics in Europe and the Middle East and 2) developing a wide portfolio of proprietary hardware solutions with first in line the Flexisense™ sensor system, aiming to empower the user by providing on demand information in the fields of Digital Health, Prosthetics, Orthotics, Diabetes, Assistive Devices, Sports and Wellbeing, and licensing to established industry participants. HCi Viocare is listed on the OTC Markets in the USA, has its executive office i...